NFL AS A POSSIBLE BIOMARKER OF TREATMENT RESPONSE IN HEREDITARY ATTR AMYLOIDOSIS: DATA FROM THE PATISIRAN APOLLO OLE STUDY

被引：0
|
作者：
Sekijima, Y. [1 ]
Polydefkis, M. [2 ]
Ticau, S. [3 ]
Erbe, D. [3 ]
McManus, A. [3 ]
Aldinc, E. [3 ]
Adams, D. [4 ]
Reilly, M. M. [5 ]
Vaishnaw, A. [3 ]
Nioi, P. [3 ]
机构：
[1] Shinshu Univ Sch Med, Dept Med Neurol & Rheumatol, Nagano, Japan
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Alnylam Pharmaceut, Cambridge, MA USA
[4] Univ Paris Saclay, APHP, CHU Bicetre, INSERM, Le Kremlin Bicetre, France
[5] UCL Queen Sq Inst Neurol, MRC Ctr Neuromuscular Dis, London, England
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2022年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [1] Neurofilament Light Chain (NfL) as a Potential Biomarker of Treatment Response in Hereditary Transthyretin-Mediated Amyloidosis: Data from the Patisiran Global OLE Study
    Polydefkis, Michael
    Ticau, Simina
    Erbe, David
    McManus, Anastasia
    Aldinc, Emre
    Adams, David
    Reilly, Mary M.
    Vaishnaw, Akshay
    Nioi, Paul
    NEUROLOGY, 2021, 96 (15)
  • [2] RESULTS FROM APOLLO PHASE III STUDY OF PATISIRAN, THE FIRST APPROVED RNAI THERAPEUTIC, IN HEREDITARY ATTR AMYLOIDOSIS PATIENTS WITH POLYNEUROPATHY.
    Zhang, X.
    Sweetser, M. T.
    Robbie, G. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S31 - S31
  • [3] Phase 2 open-label extension (OLE) study of patisiran with or without a TTR stabilizer for the treatment of hereditary ATTR (hATTR) amyloidosis with polyneuropathy
    Adams, D.
    Coelho, T.
    Conceicao, I.
    Cruz, M. Waddington
    Schmidt, H.
    Buades, J.
    Campistol, J.
    Pouget, J.
    Berk, J.
    Ziyadeh, N.
    Partisano, A.
    Chen, J.
    Sweetser, M.
    Gollob, J.
    Suhr, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 31 - 32
  • [4] Phase 2 Open-Label Extension (OLE) Study of Patisiran, an Investigational RNA interference (RNAi) Therapeutic for the Treatment of Hereditary ATTR Amyloidosis with Polyneuropathy
    Adams, David
    Coelho, Teresa
    Conceicao, Isabel
    Cruz, Marcia Waddington
    Schmidt, Hartmut
    Buades, Juan
    Campistol, Josep
    Pouget, Jean
    Berk, John
    Polydefkis, Michael
    Ziyadeh, Nour
    Partisano, Angela
    Chen, Jihong
    Gollob, Jared
    Suhr, Ole
    NEUROLOGY, 2017, 88
  • [5] PHASE 2 OPEN-LABEL EXTENSION (OLE) STUDY OF PATISIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAI) THERAPEUTIC FOR THE TREATMENT OF HEREDITARY ATTR AMYLOIDOSIS WITH POLYNEUROPATHY
    Adams, D.
    Coelho, T.
    Conceicao, E.
    Waddington-Cruz, M.
    Schmidt, H.
    Buades, J.
    Campistol, J. M.
    Pouget, J.
    Berk, J. L.
    Polydefkis, M.
    Ziyadeh, N.
    Partisano, A. M.
    Chen, J.
    Gollob, J.
    Suhr, O. B.
    VALUE IN HEALTH, 2017, 20 (05) : A211 - A212
  • [6] Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy
    David Adams
    Ole B. Suhr
    Peter J. Dyck
    William J. Litchy
    Raina G. Leahy
    Jihong Chen
    Jared Gollob
    Teresa Coelho
    BMC Neurology, 17
  • [7] Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy
    Adams, David
    Suhr, Ole B.
    Dyck, Peter J.
    Litchy, William J.
    Leahy, Raina G.
    Chen, Jihong
    Gollob, Jared
    Coelho, Teresa
    BMC NEUROLOGY, 2017, 17
  • [8] EXPLORATORY ANALYSES FROM APOLLO-B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH ATTR AMYLOIDOSIS WITH CARDIOMYOPATHY
    Cappelli, F.
    Kale, P.
    Maurer, M.
    Fontana, M.
    Grogan, M.
    Fernandes, F.
    Palacek, T.
    Taylor, M.
    Hung, R.
    Gonzalez-duarte, A.
    Puolsen, S.
    Donal, E.
    Perfetto, F.
    Tsujita, K.
    Yu, W.
    Sarswat, N.
    White, M.
    Yureneva, E.
    Jay, P.
    Vest, J.
    Gillmore, J.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [9] Exploratory Analyses From Apollo-B, A Phase 3 Study Of Patisiran In Patients With Attr Amyloidosis With Cardiomyopathy
    Kale, Parag
    Maurer, Mathew S.
    Fontana, Marianna
    Grogan, Martha
    Fernandes, Fabio
    Palecek, Tomas
    Taylor, Mark S.
    Hung, Rebecca R.
    Gonzalez-Duarte, Alejandra
    Poulsen, Steen
    Donal, Erwan
    Perfetto, Federico
    Tsujita, Kenichi
    Yu, Wen-Chung
    Sarswat, Nitasha
    White, Matthew T.
    Arum, Seth
    Jay, Patrick Y.
    Vest, John
    Gillmore, Julian
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 552 - 552
  • [10] Neurofilament light chain as a biomarker for monitoring response to change in treatment in hereditary ATTR amyloidosis
    Sato, Mitsuto
    Mochizuki, Yusuke
    Takahashi, Yusuke
    Takasone, Ken
    Aldinc, Emre
    Ticau, Simina
    Jia, Gang
    Sekijima, Yoshiki
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2023, 30 (03): : 351 - 352
12345